Apellis Pharmaceuticals, Inc. (APLS)

Apellis Pharmaceuticals Revenue

In the year 2023, Apellis Pharmaceuticals had annual revenue of $396.59M with 425.83% growth. Revenue in the quarter ending December 31, 2023 was $146.38M with 545.89% year-over-year growth.

• Revenue (ttm): $396.59M
• Revenue Growth: +425.83%
• P/S Ratio: 14.43
• Revenue / Employee: $564,944
• Employees: 702
• Market Cap: 5.72B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	396.59M	321.17M	425.83%
Dec 31, 2022	75.42M	8.86M	13.31%
Dec 31, 2021	66.56M	-184.08M	-73.44%
Dec 31, 2020	250.65M	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-
Dec 31, 2015	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.